首页> 外文期刊>Haematologica >Philadelphia chromosome-like acute lymphoblastic leukemia. Still a pending matter
【24h】

Philadelphia chromosome-like acute lymphoblastic leukemia. Still a pending matter

机译:费城染色体样急性淋巴细胞白血病。 仍然是一个待决的事情

获取原文
           

摘要

New genetic abnormalities affecting risk assess- ment and patient stratification have been reported in B-cell precursor (BCP) acute lymphoblastic leukemia (ALL) defining novel subtypes. Some of these subtypes have been included in the most recent World Health Organization classification. 1 Almost 10 years ago, two independent studies identified a subset of pediatric ALL characterized by a specific gene expression profile similar to that of Philadelphia (Ph) chromosome-positive ALL. 2,3 This novel ALL subtype, called Ph-like ALL or BCR-ABL1-like ALL, is a frequent ALL subtype that com- prises up to 15% of pediatric BCP-ALL. Its incidence reaches 25% in adolescents and young adults and 20% in adults and it is generally recognized as being associated with a poor prognosis at any age
机译:在B细胞前体(BCP)急性淋巴细胞白血病(ALL)定义新型亚型中,已报道影响风险评估和患者分层的新遗传异常。 其中一些亚型已被列入最近的世界卫生组织分类。 差不多10年前,两项独立研究确定了一种小儿的特征,其特征是一种与费城(pH)染色体阳性所有的特定基因表达谱。 2,3这种新的所有亚型,称为pH样的全部或BCR-ABL1样,是常见的所有亚型,其占额外的儿科BCP-All的15%。 它的发病率达到青少年和年轻人的25%,成年人20%,普遍认为与任何年龄的预后差有关

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号